Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), clinical areas (Expand Search)
linear decrease » linear increase (Expand Search)
decrease during » increases during (Expand Search), decreased firing (Expand Search)
Showing 21 - 40 results of 35,458 for search '(( significant ((clinical decrease) OR (linear decrease)) ) OR ( significant decrease during ))', query time: 1.10s Refine Results
  1. 21
    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  2. 22
    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  3. 23
    Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  4. 24
    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  5. 25
    Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  6. 26
    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  7. 27
    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  8. 28
    Patient and hospital characteristics associated with utilization of left atrial appendage occlusion during valvular heart surgery.

    Patient and hospital characteristics associated with utilization of left atrial appendage occlusion during valvular heart surgery. by Ayesha P. Ng (15909876)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  9. 29
    Patient, operative and hospital characteristics stratified by utilization of left atrial appendage occlusion (LAAO) during valvular heart surgery.

    Patient, operative and hospital characteristics stratified by utilization of left atrial appendage occlusion (LAAO) during valvular heart surgery. by Ayesha P. Ng (15909876)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  10. 30
    Table1_Purification of linearized template plasmid DNA decreases double-stranded RNA formation during IVT reaction.DOCX

    Table1_Purification of linearized template plasmid DNA decreases double-stranded RNA formation during IVT reaction.DOCX by Juan Martínez (4474276)

    Published 2023
    Save to List
    Saved in:
  11. 31
    A randomized trial of a behavioral intervention to decrease hospital length of stay by decreasing bedrest

    A randomized trial of a behavioral intervention to decrease hospital length of stay by decreasing bedrest by Juliana Tolles (8282265)

    Published 2020
    “…In the multivariate analysis, neither the behavioral intervention nor the provision of a recliner chair was associated with a significant decrease in length of stay or increase in functional status as measured by the ‘6-Clicks’ functional score.…”
    Save to List
    Saved in:
  12. 32
    Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).... by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  13. 33
    Risk-adjusted hospitalization costs and length of stay (LOS) associated with left atrial appendage occlusion (LAAO) utilization during valvular heart surgery.

    Risk-adjusted hospitalization costs and length of stay (LOS) associated with left atrial appendage occlusion (LAAO) utilization during valvular heart surgery. by Ayesha P. Ng (15909876)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  14. 34
    Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phas... by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  15. 35
    Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interven... by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  16. 36
    Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional pe... by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  17. 37
    Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional... by Naoya Itoh (6029276)

    Published 2023
    Save to List
    Saved in:
  18. 38
    Linear regression analysis of agreement between Mx and ORx during LBNP and LBPP experiment, all subjects; hypoxia was excluded due to its effect on cerebral saturation; Mx: transcranial Doppler-derived autoregulation index, LBNP: lower body negative pressure, LBPP: lower body positive pressure, ORx: Near-Infrared Spectroscopy derived autoregulation index.

    Linear regression analysis of agreement between Mx and ORx during LBNP and LBPP experiment, all subjects; hypoxia was excluded due to its effect on cerebral saturation; Mx: transcr... by Marcus Thudium (6441863)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  19. 39
    DataSheet1_Purification of linearized template plasmid DNA decreases double-stranded RNA formation during IVT reaction.PDF

    DataSheet1_Purification of linearized template plasmid DNA decreases double-stranded RNA formation during IVT reaction.PDF by Juan Martínez (4474276)

    Published 2023
    Save to List
    Saved in:
  20. 40
    Decreasing fluconazole susceptibility of clinical South African <i>Cryptococcus neoformans</i> isolates over a decade

    Decreasing fluconazole susceptibility of clinical South African <i>Cryptococcus neoformans</i> isolates over a decade by Serisha D. Naicker (8648370)

    Published 2020
    Save to List
    Saved in:

Search Tools: